Loading clinical trials...
Loading clinical trials...
A Phase I Study of Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
Conditions
Interventions
Lurbinectedin
Palliative Radiation Therapy
Locations
3
United States
Emory University Hospital Midtown
Atlanta, Georgia, United States
Emory University
Atlanta, Georgia, United States
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States
Start Date
July 27, 2022
Primary Completion Date
July 28, 2026
Completion Date
July 28, 2027
Last Updated
October 31, 2025
NCT06660407
NCT06500455
NCT06122064
NCT05493566
NCT04751747
NCT06031688
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions